In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...

Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

Marie Bucko joined Merck Animal Health as executive director of global public policy and stakeholder engagement. The Food and ...

New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.

Merck is part of the Zacks Large Cap Pharmaceuticals industry. Over the past month, Roche Holding AG (RHHBY), a stock from the same industry, has gained 4.8%. The company reported its results for ...

Treatment Market is expected to grow steadily, driven by the rising prevalence of hormonal disorders, infertility, and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK – Research Report) and ...

The artificial intelligence (AI) industry has been on a tear in the past two years, and judging by analyst estimates, it's ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

The global paresthesia treatment industry was valued at US$ 5.4 billion in 2023 and is projected to grow at a CAGR of 3.7% ...